Treating pancreatic tumours may have revealed cancer's master switch
Mirrored from Hacker News — AI on Front Page for archival readability. Support the source by reading on the original site.
Treating pancreatic tumours may have revealed cancer’s master switch
A promising drug could be the first of an entirely new class of treatments
Scientists are not usually an excitable bunch. So when many thousands of them recently gave a spontaneous standing ovation (with cheering) in the middle of a lecture, it meant something special happened. At a conference in Chicago at the end of May oncologists went wild over the results of a drug called daraxonrasib, which treats pancreatic cancer. The drug almost doubled median survival times from 6.7 months to 13.2 months. This victory over one of the most challenging cancers was an emotional moment for some.
New techniques can predict and prevent lung cancer
A molecular signature can identify those most at risk
Too much Chinese science is ignored by the West
A bad reputation and cultural ignorance are probably responsible
How artificial intelligence got better at building itself
What does “recursive self-improvement” mean for the technology?
The chemicals that reduce wrinkles
Vitamins, applied properly, can partially reverse the effects of ageing
Feeding 10 billion people will require new technology
Startups are combining AI and genetics to make more food for less money
Rocket goes boom; so do moon plans
The phenomenal explosion could blow a hole in Amazon’s plans and NASA’s too
Discussion (0)
Sign in to join the discussion. Free account, 30 seconds — email code or GitHub.
Sign in →No comments yet. Sign in and be the first to say something.